http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012322794-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ac18c4c20db1cd15566d5529a4b1d2e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B19-00
filingDate 2012-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a6b5649d41b0da00abaf73eb264b10d
publicationDate 2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2012322794-A1
titleOfInvention Treatment tool and method of gradual withdrawal from benzodiazepine dependency
abstract A treatment tool and method is disclosed for gradual withdrawal from benzodiazepine dependency while reducing or even minimizing withdrawal symptom intensity. An example method includes reducing emotional stress to maintain current neurotransmitter levels, stabilizing a condition with a pre-taper plan, establishing a maximum daily dosage reduction amount of benzodiazepine, based on historical data to prevent symptom escalation, reducing a current dosage of the benzodiazepine by the maximum daily dosage amount on a daily basis for up to about two weeks, and repeating establishing the maximum daily dosage reduction amount and reducing the current dosage until the daily dosage of benzodiazepine reaches zero.
priorityDate 2011-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127433480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129225114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127378182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57093972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12049213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127729747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129515347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12325869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135772871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127741279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135929945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127564392

Total number of triples: 52.